Академический Документы
Профессиональный Документы
Культура Документы
MedSlides.com 5/98
Classification
2
Acute coronary syndromes include
ST-elevation MI (STEMI)
Non ST-elevation MI ( NSTEMI)
Unstable Angina
Cardiac markers in circulation indicates
myocardial infarction and help categorize MI
and is a useful adjunct to diagnosis
MedSlides.com 5/98
History
Chest Pain- anterior precordium
3
tightness
Pain may radiate to jaw, neck and epigastrium
Dyspnea- angina equivalent, poor LV function
Nausea/abdominal pain with posterior MI
Anxiety
MedSlides.com 5/98
History
4
MedSlides.com 5/98
Physical
5
MedSlides.com 5/98
Physical
MedSlides.com 5/98
Causes
7
MedSlides.com 5/98
Causes
8
Cocaine
Arteries
Coronary anomalies
Aortic dissection
Pediatrics Kawasaki disease, Takayasu arteritis
Increased afterload which increases myocardial
demand
MedSlides.com 5/98
Risk factors for atherosclerosis
9
Age
Male gender
Smoking
Hypercholesterolemia and triglyceridemia
Diabetes Mellitus
Poorly controlled hypertension
Type A personality
MedSlides.com 5/98
Risk factors for atherosclerosis
10
Family History
Sedentary lifestyle
MedSlides.com 5/98
Differentials
11
MedSlides.com 5/98
Differentials
12
Aortic Dissection
Endocarditis
Esophagitis
Shock
Myocarditis
Pericarditis
Pulmonary embolism
MedSlides.com 5/98
Mechanisms of Myocardial damage
13
MedSlides.com 5/98
Cardiac Biomarkers
14
MedSlides.com 5/98
Troponin T and I
15
MedSlides.com 5/98
Creatinine Kinase ( CK-MB)
16
MedSlides.com 5/98
Creatine Kinase (MB)
17
MedSlides.com 5/98
Myoglobin
18
Damage to skeletal or cardiac muscle release
myoglobin into circulation
Time sequence after infarction
Rises fast 2hours
Peaks at 6-8 hours
Returns to normal in 20-36 hours
Have false positives with skeletal muscle injury
and renal failure
MedSlides.com 5/98
CBC
19
MedSlides.com 5/98
Chemistry Profile
20
MedSlides.com 5/98
C-reactive Protein (CRP)
21
MedSlides.com 5/98
Chest X-Ray
22
MedSlides.com 5/98
Echocardiography
23
MedSlides.com 5/98
Electrocardiogram
24
MedSlides.com 5/98
Localization of MI
25
ST elevation only
Inferior wall- II, III, aVF
Lateral wall_ I, aVL, V4-V6
Anteroseptal- V1-V3
Anterolateral- V1-V6
Right ventricular- RV4, RV5
Posterior- R/S ratio >1 in V1 and T wave inversion
MedSlides.com 5/98
Ischemia & Infarction
• Indications of an acute infarction
• Usually no ECG changes are seen in the first few minutes after occlusion
• Appearance of tall narrow T-waves or ST-segment elevation
• 5 to 30 minutes post occlusion
• A few hours later, the T-waves invert (ischemia)
• in an MI, the T-wave inversion is symmetrical an may persist for years
• inverted T-waves without other indications are not diagnostic of an MI
• ST-segment elevation – indication of injury (although it may be reversible)
• ST-elevation may also indicate transmural ischemia
• usually the first definite sign of an infarction
• may or may not be accompanied by T-wave inversion
• 1mm or more in limb leads or 2mm or more in precordial leads
• differentiate between early repolarization or “J-point elevation”
• the larger the ischemic area, the greater the ST displacement
• ST elevation persisting for more than a few hours may indicate ventricular aneurysm
• ST depression may be seen in reciprocal leads.
MedSlides.com 26 5/98
Ischemia & Infarction
Acute anteriolateral MI
MedSlides.com 27 5/98
Ischemia & Infarction
• Biomarkers in an MI:
50
Myoglobin
20 Cardiac Troponin
Multiples of the AMI cutoff Limit
CK-MB
10
Cardiac Troponin after unstable angina
1
AMI decision limit
Upper normal limit
0
0 1 2 3 4 5 6 7 8
Days after MI Onset
MedSlides.com 28 5/98
Ischemia & Infarction
Old Inferior MI
MedSlides.com 29 5/98
Therapy
30
MedSlides.com 5/98
Antiplatelet Agents
Aspirin at lease 160mg31immediately
Interferes with function of cyclooxygenase and
inhibits the formation of thromboxane
ASA alone has one of the greatest impact on the
reduction of MI mortality.
Clopidogrel, ticlopidine, have not been shown in
any large scal trail to be superior to Aspirin in
acute MI
MedSlides.com 5/98
Supplemental
32
Oxygen
MedSlides.com 5/98
Nitrates
IV nitrates to all patients with MI and
33
congestive heart failure, persistent ischemia,
hypertension, or large anterior wall MI
Primary benefit vasodilator effect
Metabolized to nitric oxide in the vascular
endothelium, relaxes endothelium
Vasodilatation reduces myocardial oxygen
demand and preload and afterload
MedSlides.com 5/98
Beta-blockers
34
MedSlides.com 5/98
Unfractionated heparin
35
MedSlides.com 5/98
Low-molecular weight heparin
36
Direct activity against factors Xa and IIa
Proven to be effective in treating ACS that are
characterized by unstable angina or non ST-
elevation MI
Their fixed doses are easy to administer and
laboratory testing to measure their therapeutic
effect is not necessary makes them attractive
alternative of un-fractionated heparin
MedSlides.com 5/98
Thrombolytics
37
MedSlides.com 5/98
Thrombolytics
38
As a class the plasminogen activators have
been shown to restore coronary blood flow in
50-80% of patients
Contraindication active intracranial bleeding,
CVA 2months, CNS neoplasm, HTN,
coagulopathy
Retaplase slightly higher angiographic
patency but did not translate into survival
benefit
Intracranial bleed risk major drawback
MedSlides.com 5/98
Glycoprotein IIb/IIIa Antagonists
39
MedSlides.com 5/98
Surgical Revascularization
40
Emergent or surgical revascularization in
setting of failed PTCA in patients with
hemodynamic instability and coronary anatomy
amendable to surgical grafting
Also indicated of mechanical complications of
MI including VSD, free wall rupture, or acute
MR
Carries a higher risk of perioperative mortality
than elective CABG
MedSlides.com 5/98
Lipid Management
41
All post MI patients should be on AMA step II
diet ( < 7% of calories from saturated fats)
Post MI patients with LDL > 100 mg/dl are
recommended to be on drug therapy to try to
lower levels to <100 mg/dl
Recent data indicate that all MI patients should
be on statin therapy, regardless of lipid levels or
diet
MedSlides.com 5/98
Long term Medications
42
MedSlides.com 5/98